2 results match your criteria: "Children's Memorial Hospital and Northwestern University's Feinberg School of Medicine[Affiliation]"
Therapeutic approaches using nitric oxide in infants and children.
Free Radic Biol Med
September 2011
Department of Pediatrics, Children's Memorial Hospital and Northwestern University's Feinberg School of Medicine, Chicago, IL 60614, USA.
Pulmonary hypertension contributes significantly to the morbidity and mortality associated with many pediatric pulmonary and cardiac diseases. Nitric oxide, a gas molecule, is a unique pharmaceutical agent that can be inhaled and thus delivered directly to the lung. Inhaled nitric oxide was approved by the FDA in 1999 as a therapy for infants with persistent pulmonary hypertension.
View Article and Find Full Text PDFParents' reactions to participating in interviews about end-of-life decision making.
J Palliat Med
December 2006
Department of Pediatrics, Children's Memorial Hospital and Northwestern University's Feinberg School of Medicine, Chicago, Illinois 60614, USA.
Background: Although in-depth interviewing is well suited to studying the sensitive topic of end-of-life decision making, no reports have been published assessing the effects on parents of participating in interviews regarding end-of-life decision making for critically ill children.
Objective: To examine the reactions of pediatric intensive care unit (PICU) patients' parents to interviews on end-of-life decision making for their child.
Methods: We conducted semistructured interviews on end-of-life decision making with PICU patients' parents from two tertiary care PICUs.